NM_017950.4:c.1144G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_017950.4(CCDC40):​c.1144G>A​(p.Glu382Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000848 in 1,566,090 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E382D) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00070 ( 3 hom., cov: 32)
Exomes 𝑓: 0.00086 ( 15 hom. )

Consequence

CCDC40
NM_017950.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.840

Publications

5 publications found
Variant links:
Genes affected
CCDC40 (HGNC:26090): (coiled-coil domain 40 molecular ruler complex subunit) This gene encodes a protein that is necessary for motile cilia function. It functions in correct left-right axis formation by regulating the assembly of the inner dynein arm and the dynein regulatory complexes, which control ciliary beat. Mutations in this gene cause ciliary dyskinesia type 15, a disorder due to defects in cilia motility. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]
CCDC40 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 15
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autoimmune disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005613655).
BP6
Variant 17-80050268-G-A is Benign according to our data. Variant chr17-80050268-G-A is described in ClinVar as Benign. ClinVar VariationId is 226487.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000703 (107/152280) while in subpopulation EAS AF = 0.0178 (92/5172). AF 95% confidence interval is 0.0149. There are 3 homozygotes in GnomAd4. There are 70 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCDC40NM_017950.4 linkc.1144G>A p.Glu382Lys missense_variant Exon 7 of 20 ENST00000397545.9 NP_060420.2 Q4G0X9-1
CCDC40NM_001243342.2 linkc.1144G>A p.Glu382Lys missense_variant Exon 7 of 18 NP_001230271.1 Q4G0X9-2
CCDC40NM_001330508.2 linkc.1144G>A p.Glu382Lys missense_variant Exon 7 of 11 NP_001317437.1 Q4G0X9-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC40ENST00000397545.9 linkc.1144G>A p.Glu382Lys missense_variant Exon 7 of 20 5 NM_017950.4 ENSP00000380679.4 Q4G0X9-1

Frequencies

GnomAD3 genomes
AF:
0.000690
AC:
105
AN:
152162
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0177
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00178
AC:
302
AN:
169920
AF XY:
0.00178
show subpopulations
Gnomad AFR exome
AF:
0.000111
Gnomad AMR exome
AF:
0.0000386
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0224
Gnomad FIN exome
AF:
0.0000612
Gnomad NFE exome
AF:
0.0000579
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000864
AC:
1221
AN:
1413810
Hom.:
15
Cov.:
34
AF XY:
0.000878
AC XY:
614
AN XY:
699470
show subpopulations
African (AFR)
AF:
0.0000312
AC:
1
AN:
32086
American (AMR)
AF:
0.00
AC:
0
AN:
37314
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25358
East Asian (EAS)
AF:
0.0296
AC:
1089
AN:
36744
South Asian (SAS)
AF:
0.000876
AC:
71
AN:
81090
European-Finnish (FIN)
AF:
0.000201
AC:
10
AN:
49800
Middle Eastern (MID)
AF:
0.000735
AC:
3
AN:
4082
European-Non Finnish (NFE)
AF:
0.0000193
AC:
21
AN:
1088802
Other (OTH)
AF:
0.000444
AC:
26
AN:
58534
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
79
158
236
315
394
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000703
AC:
107
AN:
152280
Hom.:
3
Cov.:
32
AF XY:
0.000940
AC XY:
70
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41562
American (AMR)
AF:
0.00
AC:
0
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.0178
AC:
92
AN:
5172
South Asian (SAS)
AF:
0.00249
AC:
12
AN:
4820
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68014
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.518
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000947
Hom.:
4
Bravo
AF:
0.000699
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.00125
AC:
146
Asia WGS
AF:
0.00837
AC:
29
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:2
Apr 15, 2019
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Glu382Lys in exon 7 of CCDC40: This variant is not expected to have clinical sig nificance because it has been identified in 5.2% (10/194) of Han Chinese chromos omes from a broad population by the 1000 Genomes Project (http://www.ncbi.nlm.ni h.gov/projects/SNP; dbSNP rs2289532). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Primary ciliary dyskinesia 15 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
15
DANN
Benign
0.92
DEOGEN2
Benign
0.13
.;T;.;.
Eigen
Benign
-0.71
Eigen_PC
Benign
-0.83
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.80
T;T;T;T
MetaRNN
Benign
0.0056
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.9
L;L;L;L
PhyloP100
0.84
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-2.1
N;N;N;N
REVEL
Benign
0.030
Sift
Benign
0.27
T;T;T;T
Sift4G
Benign
0.60
T;T;T;T
Polyphen
0.35, 0.98
.;B;.;D
Vest4
0.23
MVP
0.14
MPC
0.21
ClinPred
0.020
T
GERP RS
1.5
Varity_R
0.079
gMVP
0.058
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2289532; hg19: chr17-78024067; COSMIC: COSV53901275; COSMIC: COSV53901275; API